An international team of researchers have developed a ‘promising’ new drug which could help combat the spread of treatment-resistant malaria. The breakthrough development is the first to adapt an approach from cancer treatments to tackle malaria. It works by permanently disabling a protein that Plasmodium falciparum, one of the mosquito-borne parasites which spreads malaria, uses to duplicate itself inside the … Read more
Keltic Pharma Therapeutics, a University of Glasgow Spin-Out, Awarded SMART Grant by Innovate UK to Develop Groundbreaking Drug Discovery Platform, PEPSMOL©. Glasgow, UK — Keltic Pharma Therapeutics, a spin-out from the laboratories of Professor Andrew Tobin, Professor Andrew Jameson, and Professor Graeme Milligan at the University of Glasgow, is proud to announce that it has been … Read more
https://www.bps.ac.uk/news/articles/2023/honorary-fellows-recognised-in-2023-new-year-honour
https://www.rsc.org/membership-and-community/connect-with-others/through-interests/interest-groups/cbbg/awards/#2023-winner-expanded
https://www.linkedin.com/posts/keltic-pharma-therapeutics_proud-lifesciences-activity
Professor Graeme Milligan and Professor Andrew Tobin have worked together for more than 10 years to establish ‘Translational Pharmacology’ as a theme of excellence at University of Glasgow. They have cultivated extensive and highly productive links with both early-stage and major international biopharmaceutical companies. Building on the insights gained, they have developed their research interests … Read more
A University of Glasgow spinout company has received a substantial multi-million Euro award from the European Union (EU) Malaria Fund, to extend their world-leading malaria research into a drug that will hopefully, one day, cure malaria and prevent the disease from spreading. The newly-established Keltic Pharma Therapeutics Ltd – co-founded by Professor Andrew Tobin, Professor … Read more